Zhejiang Starry Pharmaceutical Co.,Ltd. (SHA:603520)
China · Delayed Price · Currency is CNY 10.66
-0.10 (-0.93%)
Apr 9, 2026, 3:00 PM CST
SHA:603520 Market Cap
SHA:603520 has a market cap or net worth of 4.67 billion as of April 9, 2026. Its market cap has increased by 26.90% in one year.
Market Cap
4.67B
Enterprise Value
7.04B
Revenue
2.39B
Ranking
n/a
PE Ratio
n/a
Stock Price
10.66
Market Cap Chart
Since March 9, 2016, SHA:603520's market cap has increased from 2.10B to 4.67B, an increase of 122.55%. That is a compound annual growth rate of 8.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 4.67B | 13.40% |
| Dec 31, 2025 | 4.12B | 8.17% |
| Dec 31, 2024 | 3.81B | -21.00% |
| Dec 29, 2023 | 4.82B | -27.95% |
| Dec 30, 2022 | 6.69B | -57.86% |
| Dec 31, 2021 | 15.89B | -1.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tibet Duo Rui Pharmaceutical | 4.92B |
| Zhuhai Rundu Pharmaceutical | 4.86B |
| Newland Pharmaceutical | 4.80B |
| Hunan Fangsheng Pharmaceutical | 4.79B |
| Shandong Sinobioway Biomedicine | 4.74B |
| Yabao Pharmaceutical Group | 4.71B |
| Tibet Weixinkang Medicine | 4.67B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 4.55B |